Genpharm is a Dubai-based regional company providing market access and marketing solutions for rare disease products in the MENA region. Co-Founders Karim Smaira and Kamel Ghammachi provide insights into the rare disease space in the region, explain how the company is positioning itself in the gene therapy arena and why innovative treatments are bound for success in the GCC countries. Moreover, they reveal the challenges of starting their own company in the MENA pharmaceutical industry.
Change should be part of our daily life. Genpharm has been always centred around being an agile and dynamic organization
